Recombinant Ashbya gossypii 3-ketoacyl-CoA reductase (ADR059C)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Ashbya gossypii 3-ketoacyl-CoA Reductase (ADR059C)

Recombinant Ashbya gossypii 3-ketoacyl-CoA reductase (ADR059C) is an enzyme involved in the fatty acid biosynthesis pathway. This enzyme plays a crucial role in reducing 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, a key step in the elongation of fatty acid chains. Ashbya gossypii, a filamentous fungus, is known for its ability to produce riboflavin and has been engineered for various biotechnological applications, including lipid production.

Function and Role in Fatty Acid Synthesis

In the context of fatty acid synthesis, 3-ketoacyl-CoA reductase is essential for the conversion of 3-ketoacyl-CoA into 3-hydroxyacyl-CoA. This step is part of the fatty acid synthase complex, which is responsible for elongating acyl chains. The enzyme's activity ensures the proper formation of fatty acids, which are vital components of cellular membranes and energy storage molecules.

Table: Comparison of Lipid Accumulation in Engineered Ashbya gossypii Strains

Strain ModificationLipid Content (% of Cell Dry Weight)
Wild-typeLower than engineered strains
pox1ΔUp to 70%
pox1Δ with ACL overexpressionApproximately 60%

ELISA Kits for Detection

ELISA kits are available for detecting recombinant Ashbya gossypii 3-ketoacyl-CoA reductase, facilitating quantitative analysis of the enzyme in various samples . These kits are useful for research purposes, allowing scientists to monitor enzyme expression levels and activity in different experimental conditions.

References Engineering Ashbya gossypii for efficient biolipid production. PMC4601342. ELISA Recombinant Ashbya gossypii 3-ketoacyl-CoA reductase. The improvement of riboflavin production in Ashbya gossypii via disparity mutagenesis and DNA microarray analysis. Peroxisomal Fatty Acid β-Oxidation Is Not Essential for Virulence of Candida albicans. Production of riboflavin and related cofactors by biotechnological processes.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on purchasing method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
If you require a specific tag type, please specify this during your order; we will prioritize its use during production.
Synonyms
ADR059C; Very-long-chain 3-oxoacyl-CoA reductase; 3-ketoacyl-CoA reductase; 3-ketoreductase; KAR; Microsomal beta-keto-reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-351
Protein Length
full length protein
Species
Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) (Yeast) (Eremothecium gossypii)
Target Names
ADR059C
Target Protein Sequence
MGSLSDISFFDHLQELARRDCCVNALLWCAFTVGAVKLTTFMLSLISIALETTVLPSASY KKYGARKGAYALVTGASDGIGKEFALQLASKGFNVLLVSRTEAKLLELKQEIMAKYKVDA RVLSVDFGVDNRLTYTAISELCGELPVTVLVNNVGVSHSIPVSFLETTEEELRGIITVNN TATLMVTQTVAPLVIANARRLQCRGLVLTMGSFDGLLPTPLLATYSGSKDFVQAWSTALV VDLAPLNVDVQIVLSYLVTSAMSKVRRASALIATPRAFVRSTLASLGHRVGAQERYATCT PYWSHALYHFLIENTVGVHSRLANAINYRFHADIRKRALRKAARKAAEKQE
Uniprot No.

Target Background

Function

Recombinant Ashbya gossypii 3-ketoacyl-CoA reductase (ADR059C) is a component of the microsomal membrane-bound fatty acid elongation system. This enzyme is responsible for the production of 26-carbon very long-chain fatty acids (VLCFAs) from palmitate. Its function involves catalyzing the reduction of the 3-ketoacyl-CoA intermediate generated in each cycle of fatty acid elongation. These VLCFAs serve as precursors for ceramide and sphingolipids.

Database Links
Protein Families
Short-chain dehydrogenases/reductases (SDR) family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass membrane protein.

Q&A

What are the key properties of recombinant ADR059C protein?

The recombinant ADR059C protein possesses several important properties that researchers should consider when designing experiments:

PropertyDescriptionReference
Source OrganismAshbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056)
UniProt AccessionQ75A60
Full Length351 amino acids
Expression SystemE. coli
Affinity TagHis-tag (common)
Storage Conditions-20°C (short-term); -80°C (long-term)
Buffer CompatibilityTris-based buffer with 50% glycerol
Recommended Working ConditionsStore working aliquots at 4°C for up to one week; avoid repeated freeze-thaw cycles

What biological pathways involve ADR059C?

Based on its classification as a 3-ketoacyl-CoA reductase, ADR059C likely participates in fatty acid biosynthesis pathways. This enzyme typically catalyzes the second of four reactions in the fatty acid elongation cycle, specifically the NADPH-dependent reduction of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA. While the search results do not provide specific pathway information for ADR059C , its enzymatic classification suggests involvement in:

  • De novo fatty acid synthesis

  • Fatty acid elongation processes

  • Lipid metabolism

  • Potentially secondary metabolite production

Researchers should confirm the specific pathways through experimental validation, such as metabolic profiling or pathway reconstruction studies.

How should I design an experiment to characterize ADR059C enzymatic activity?

Designing a robust experiment to characterize ADR059C enzymatic activity requires careful consideration of multiple variables. Following Quality by Design (QbD) principles can enhance experimental rigor . A comprehensive experimental design should include:

Independent Variables:

  • Substrate concentration (e.g., 0.5 mM, 1.0 mM, 2.0 mM)

  • Enzyme concentration

  • pH (typically testing a range from 5.0-9.0)

  • Temperature (e.g., 25°C, 30°C, 37°C, 42°C)

  • Cofactor concentration (NADPH)

Dependent Variable:

  • Reaction rate (nmol/min/mg protein or specific activity units)

Controlled Variables:

  • Buffer composition

  • Ionic strength

  • Reaction time

  • Mixing/agitation rate

Constants:

  • Assay volume

For optimal experimental design, implement a factorial design analysis to identify significant factors affecting enzyme activity . This allows for systematic investigation of multiple parameters simultaneously while minimizing the number of experiments required.

A typical workflow would include:

  • Initial screening experiments to identify approximate optimal conditions

  • Response surface modeling to pinpoint optimal conditions

  • Validation experiments under optimized conditions

  • Kinetic characterization (Km, Vmax, kcat determination)

What are the critical parameters for maintaining ADR059C stability during experiments?

Several critical parameters affect ADR059C stability during experimental procedures:

  • Storage Conditions: Store purified recombinant ADR059C at -20°C for short-term or -80°C for extended storage in a Tris-based buffer with 50% glycerol .

  • Working Solution Preparation: Prepare working aliquots and store at 4°C for up to one week. Avoid repeated freeze-thaw cycles as they can significantly reduce enzyme activity .

  • Temperature Sensitivity: While optimal reaction temperature may vary based on experimental goals, avoid exposing the enzyme to temperatures above 42°C for extended periods as this may lead to denaturation.

  • pH Stability: The optimal pH range for enzyme stability may differ from the optimal pH for activity. Typically, maintaining the enzyme in a buffer system with pH 7.0-8.0 during storage helps preserve structural integrity.

  • Stabilizing Agents: Consider adding stabilizing agents such as DTT (1-5 mM) to prevent oxidation of cysteine residues, or low concentrations of glycerol (10-20%) to prevent protein aggregation.

A systematic approach to evaluating stability parameters would involve monitoring enzymatic activity over time under various storage and handling conditions, similar to approaches used in Quality by Design for enzyme-catalyzed reactions .

How can I develop a reliable assay to measure ADR059C activity?

Developing a reliable assay for ADR059C activity requires consideration of the enzymatic reaction it catalyzes. As a 3-ketoacyl-CoA reductase, it likely catalyzes the NADPH-dependent reduction of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA. Here's a methodological approach:

Spectrophotometric Assay:

  • Principle: Monitor the oxidation of NADPH to NADP+ at 340 nm (decrease in absorbance)

  • Components:

    • Recombinant ADR059C (purified enzyme)

    • 3-ketoacyl-CoA substrate (various chain lengths can be tested)

    • NADPH (cofactor)

    • Appropriate buffer (typically Tris or phosphate)

  • Controls:

    • No-enzyme control

    • Heat-inactivated enzyme control

    • Substrate specificity controls (different acyl chain lengths)

Assay Optimization:

  • Determine linear range of enzyme concentration

  • Establish optimal substrate concentrations

  • Identify optimal pH and temperature

  • Validate reproducibility with replicate measurements

Data Analysis:

  • Calculate specific activity (μmol NADPH oxidized/min/mg protein)

  • Derive kinetic parameters (Km, Vmax) using appropriate regression models

  • Assess substrate specificity profiles

For robust assay development, implement quality by design principles to systematically identify and control variables that might affect assay performance. This includes screening designs to identify critical parameters and response surface modeling to optimize conditions.

What approaches can be used to investigate substrate specificity of ADR059C?

Investigating the substrate specificity of ADR059C requires a systematic approach that combines biochemical assays with structural analysis:

Experimental Approaches:

  • Substrate Panel Testing: Prepare a panel of 3-ketoacyl-CoA substrates with varying:

    • Chain lengths (C4-C18)

    • Saturation levels (saturated vs. unsaturated)

    • Branch points (straight chain vs. branched)

  • Kinetic Parameter Determination: For each substrate, determine:

    • Km (substrate affinity)

    • kcat (catalytic rate)

    • kcat/Km (catalytic efficiency)

  • Competitive Substrate Assays: Test pairs of substrates in competition experiments to assess relative preferences.

  • Structure-Function Analysis: If crystal structure data becomes available, correlate substrate binding pocket characteristics with substrate preferences.

Data Analysis Methodology:

Create a substrate specificity profile using a heat map or radar chart representation of catalytic efficiency values across different substrates. Apply principal component analysis to identify patterns in substrate preference that may correlate with specific structural features.

For statistical validation of specificity differences, implement appropriate ANOVA designs followed by post-hoc tests, similar to the factorial design analysis approaches described in experimental design literature .

How can I investigate the structural determinants of ADR059C function?

Investigating structural determinants of ADR059C function requires an integrated approach combining computational and experimental methodologies:

Computational Approaches:

  • Homology Modeling: Generate a 3D structural model of ADR059C based on closely related 3-ketoacyl-CoA reductases with known crystal structures.

  • Molecular Docking: Dock potential substrates and cofactors to identify key binding residues and interaction patterns.

  • Molecular Dynamics Simulations: Simulate enzyme-substrate-cofactor interactions to understand dynamic aspects of binding and catalysis.

  • Evolutionary Analysis: Perform multiple sequence alignment of related 3-ketoacyl-CoA reductases to identify conserved residues likely crucial for function.

Experimental Validation:

  • Site-Directed Mutagenesis: Based on computational predictions, generate targeted mutations of:

    • Predicted catalytic residues

    • Substrate binding pocket residues

    • Cofactor binding site residues

  • Kinetic Analysis of Mutants: Compare catalytic parameters of wild-type and mutant proteins to quantify the impact of specific residues on:

    • Substrate binding (Km)

    • Catalytic efficiency (kcat/Km)

    • Reaction mechanism

  • Biophysical Characterization: Employ techniques such as:

    • Circular dichroism to assess structural changes

    • Thermal shift assays to determine stability alterations

    • Isothermal titration calorimetry to measure binding energetics

This multifaceted approach provides robust evidence for structure-function relationships in ADR059C and can guide rational engineering of the enzyme for enhanced properties or altered specificity.

What methods are appropriate for studying ADR059C in its native cellular context?

Studying ADR059C in its native context within Ashbya gossypii requires approaches that preserve the physiological environment while allowing specific measurement of enzyme function:

In Vivo Approaches:

  • Gene Knockout/Knockdown: Use CRISPR-Cas9 or RNAi techniques to modulate ADR059C expression levels and observe phenotypic consequences, particularly in lipid profiles.

  • Reporter Systems: Create fusion constructs (e.g., ADR059C-GFP) to monitor protein localization and expression dynamics under different conditions.

  • Metabolic Labeling: Use radioactive or stable isotope-labeled precursors to trace metabolic flux through ADR059C-dependent pathways.

  • Proteomics Approaches:

    • Proximity labeling to identify interaction partners

    • Phosphoproteomics to detect regulatory modifications

    • Thermal proteome profiling to assess in-cell target engagement

Experimental Design Considerations:

When designing such studies, apply principles of experimental design by identifying:

  • Independent variables (e.g., growth conditions, carbon sources)

  • Dependent variables (e.g., lipid profiles, growth rates)

  • Controlled variables (e.g., temperature, media composition)

  • Experimental controls (e.g., wild-type strains, enzyme-dead mutants)

For complex factorial designs investigating multiple variables, apply statistical approaches such as response surface methodology to efficiently map the relationship between experimental conditions and biological responses.

How can I address inconsistent activity measurements with recombinant ADR059C?

Inconsistent activity measurements with recombinant ADR059C can stem from multiple sources. Here is a systematic troubleshooting approach:

Common Sources of Variability and Solutions:

  • Enzyme Stability Issues:

    • Problem: Activity loss during storage or experimentation

    • Solutions:

      • Aliquot enzyme and avoid repeated freeze-thaw cycles

      • Add stabilizing agents (glycerol, reducing agents)

      • Validate activity before each experimental session

  • Assay Component Variability:

    • Problem: Batch-to-batch variation in substrates or cofactors

    • Solutions:

      • Establish internal standards for assay validation

      • Prepare larger batches of critical reagents

      • Include positive controls with known activity

  • Environmental Factors:

    • Problem: Uncontrolled temperature or pH fluctuations

    • Solutions:

      • Monitor and record environmental conditions

      • Use temperature-controlled instruments

      • Implement buffering capacity tests

  • Procedural Inconsistencies:

    • Problem: Variations in handling or timing

    • Solutions:

      • Develop detailed standard operating procedures

      • Automate critical steps where possible

      • Implement quality by design principles

Statistical Approach to Variability Assessment:

Implement a designed experiment to systematically evaluate sources of variability:

  • Conduct a multi-factor design including operator, reagent batch, and day as factors

  • Calculate variance components to identify primary sources of variability

  • Establish acceptance criteria based on statistical process control principles

This methodical approach helps distinguish random variation from systematic issues and guides targeted improvements to assay reliability.

What statistical approaches are most appropriate for analyzing ADR059C enzyme kinetics data?

Kinetic Parameter Estimation:

  • Non-linear Regression Methods:

    • Michaelis-Menten equation fitting for simple kinetics

    • Expanded models for complex kinetics (substrate inhibition, allosteric effects)

    • Weighted regression to account for heteroscedasticity (common in enzyme assays)

  • Linearization Methods (for visual inspection, not primary analysis):

    • Lineweaver-Burk plot (1/v vs. 1/[S])

    • Eadie-Hofstee plot (v vs. v/[S])

    • Hanes-Woolf plot ([S]/v vs. [S])

Statistical Validation and Comparison:

  • Parameter Uncertainty Estimation:

    • Calculate confidence intervals for Km and Vmax

    • Use bootstrapping for robust error estimation

    • Perform residual analysis to validate model assumptions

  • Comparative Analysis:

    • ANOVA for comparing multiple conditions

    • Extra sum-of-squares F-test for nested model comparison

    • AIC (Akaike Information Criterion) for model selection

  • Experimental Design Considerations:

    • Use factorial designs to efficiently explore multiple factors

    • Implement response surface methodology for optimization

    • Apply blocking techniques to control for batch effects

For robust analysis, implement the following workflow:

  • Preliminary data visualization to identify patterns

  • Model fitting with appropriate weighting

  • Residual analysis to validate assumptions

  • Parameter estimation with confidence intervals

  • Model comparison when multiple mechanisms are plausible

How can I properly design experiments to detect inhibitors or activators of ADR059C?

Designing robust experiments to identify and characterize inhibitors or activators of ADR059C requires careful consideration of experimental variables and controls:

Experimental Design Framework:

  • Screening Assay Development:

    • Optimize signal-to-noise ratio for primary screening

    • Establish Z' factor >0.5 for assay robustness

    • Determine appropriate positive and negative controls

    • Select substrate concentration near Km for optimal sensitivity

  • Inhibition Mechanism Characterization:

    • Design a matrix experiment varying both substrate and inhibitor concentrations

    • Include multiple substrate concentrations (0.5-5× Km)

    • Test several inhibitor concentrations in a logarithmic series

    • Include no-inhibitor controls for each substrate concentration

  • Mode of Inhibition Analysis:

    • Generate Lineweaver-Burk plots for visual inspection

    • Fit data to competitive, noncompetitive, uncompetitive, and mixed inhibition models

    • Select best model using statistical criteria (AIC, extra sum-of-squares F-test)

  • Statistical Analysis Approach:

    • Apply factorial design principles to efficiently explore multiple variables

    • Use regression modeling to quantify inhibitor potency (IC50, Ki)

    • Implement response optimization to identify conditions that maximize inhibition detection sensitivity

For activation studies, a similar framework applies, but with modifications to detect enhanced activity rather than inhibition. The experimental design should include response surface modeling to characterize the relationship between activator concentration, substrate concentration, and enzyme activity.

How can ADR059C be utilized in metabolic engineering applications?

ADR059C, as a 3-ketoacyl-CoA reductase, holds significant potential for metabolic engineering applications focused on lipid and fatty acid production pathways:

Potential Applications:

  • Biofuel Production:

    • Engineering microorganisms for enhanced fatty acid synthesis using ADR059C variants

    • Optimizing the reduction step in fatty acid elongation to improve carbon flux toward desired products

    • Creating synthetic pathways incorporating ADR059C for novel biofuel precursor production

  • Specialty Lipid Production:

    • Modifying substrate specificity of ADR059C to produce unusual or valuable fatty acids

    • Controlling chain length specificity to target specific lipid products

    • Balancing metabolic flux through coordinated expression with other pathway enzymes

  • Pathway Optimization Strategy:

    • Identify rate-limiting steps in fatty acid biosynthesis through systematic analysis

    • Apply quality by design principles to optimize expression and activity of ADR059C in heterologous hosts

    • Balance cofactor (NADPH) availability with enzyme activity levels

Experimental Approach:

  • Conduct pathway flux analysis to identify bottlenecks

  • Design ADR059C variants with altered properties using structure-guided mutagenesis

  • Implement dynamic regulation strategies for optimal pathway performance

  • Apply response surface methodology to optimize multiple parameters simultaneously

For successful metabolic engineering applications, researchers should employ experimental design frameworks that systematically explore the multidimensional parameter space affecting pathway performance.

What advanced techniques can be used to study protein-protein interactions involving ADR059C?

Investigating protein-protein interactions (PPIs) involving ADR059C requires a multi-technique approach to capture both stable and transient interactions:

In Vitro Methods:

  • Co-Immunoprecipitation with Tagged Recombinant ADR059C:

    • Express His-tagged ADR059C in heterologous systems

    • Perform pull-down experiments followed by mass spectrometry

    • Validate interactions with reciprocal co-IP experiments

  • Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI):

    • Immobilize purified ADR059C on sensor chips

    • Measure binding kinetics (kon, koff) and affinities (KD) with potential partners

    • Compare wild-type and mutant interactions to identify interface residues

  • Crosslinking Mass Spectrometry:

    • Apply chemical crosslinkers to stabilize transient interactions

    • Identify crosslinked peptides by LC-MS/MS

    • Generate structural models of protein complexes

In Vivo Methods:

  • Proximity-Dependent Labeling:

    • Create ADR059C fusion with BioID or APEX2

    • Identify proximal proteins through biotinylation and streptavidin pull-down

    • Map the spatial interactome in native cellular contexts

  • Fluorescence-Based Techniques:

    • Bimolecular Fluorescence Complementation (BiFC)

    • Förster Resonance Energy Transfer (FRET)

    • Fluorescence Cross-Correlation Spectroscopy (FCCS)

Experimental Design Considerations:

When designing PPI studies, implement a factorial approach that systematically varies:

  • Environmental conditions (pH, ionic strength)

  • Post-translational modification states

  • Substrate or product presence

  • Cellular compartments or microenvironments

This comprehensive approach will provide insights into the dynamic interactome of ADR059C and its role within larger metabolic complexes or signaling networks.

What are the current challenges and emerging solutions in ADR059C research?

Research on ADR059C faces several challenges that are being addressed through innovative approaches:

Current Challenges:

  • Structural Characterization:

    • Challenge: Limited structural information about ADR059C

    • Emerging Solutions:

      • Cryo-EM for structure determination without crystallization

      • AlphaFold2 and related AI tools for structure prediction

      • Integrative structural biology combining multiple data sources

  • Functional Redundancy:

    • Challenge: Potential redundancy with other reductases making phenotypic analysis difficult

    • Emerging Solutions:

      • Multiplexed CRISPR screening for synthetic interactions

      • Metabolic flux analysis to quantify pathway contributions

      • Single-cell approaches to detect compensatory mechanisms

  • In Vivo Activity Measurement:

    • Challenge: Difficulty in measuring native enzyme activity within cells

    • Emerging Solutions:

      • Genetically encoded biosensors for metabolic intermediates

      • Activity-based protein profiling with specific probes

      • Spatially resolved metabolomics

Experimental Design Innovations:

To address these challenges, researchers are implementing novel experimental design approaches:

  • Machine learning-guided experimental design to predict optimal conditions

  • High-dimensional experimental designs that efficiently explore complex parameter spaces

  • Adaptive experimental protocols that iteratively refine hypotheses based on incoming data

For researchers entering this field, a systematic approach based on quality by design principles will be essential to navigate these challenges efficiently. This includes:

  • Clear definition of the scientific question

  • Risk assessment of potential experimental pitfalls

  • Design of experiments that maximize information content

  • Implementation of robust statistical analysis frameworks

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.